SS

Santosh Sadanand Mahatme

Director Director DIN 03464390
DIN 03464390 First appointment Apr 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2011
Shareholding value •••• Premium profile

About Santosh Sadanand Mahatme

Data last updated:

Santosh Sadanand Mahatme was a Director at A.Menarini India Private Limited (2011–2012) and Director at Inovail Pharmaceuticals (India) Private Limited (2011–2012). The companies operate in Pharma and Chemicals.

DIN 03464390
Primary Designation Director
Industry Pharma
First Appointment 07 Apr 2011

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
A.Menarini India Private Limited U74130GJ2001PTC039600
Director07 Apr 20112001₹166 Cr (FY 2025)Active
Director07 Apr 20112008Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
A.Menarini India Private Limited
Inovail Pharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Santosh Sadanand Mahatme

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Sadanand Mahatme

Santosh Sadanand Mahatme was first appointed on 07 Apr 2011 as Director at A.Menarini India Private Limited.

Santosh Sadanand Mahatme held 2 earlier board appointments: A.Menarini India Private Limited (Director, 07 Apr 2011 to 10 Apr 2012); Inovail Pharmaceuticals (India) Private Limited (Director, 07 Apr 2011 to 10 Apr 2012).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available